Related Experiment Video
Updated: Jun 24, 2026

07:47
Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
Pneumococcal seroepidemiology in Turkey: implications for vaccine coverage
Vaccine
|February 15, 2008
Summary
This study identifies prevalent pneumococcal serotypes in Turkey. Modifying current vaccines, like PCV-7 and PPV-23, could significantly enhance pneumococcal conjugate vaccine coverage in the Turkish population.
Area of Science:
- Bacteriology
- Immunology
- Public Health
Background:
- Pneumococcal infections remain a significant public health concern globally.
- Understanding prevalent serotypes is crucial for effective vaccine development and deployment.
- Recent Turkish studies highlight specific pneumococcal serotypes circulating within the population.
Discussion:
- The current Pneumococcal Conjugate Vaccine 7 (PCV-7) formulation covers only 38.3% of invasive pneumococcal infections (IPI) in Turkey.
- Replacing serotypes/groups 4, 9V, and 18C in PCV-7 with 1, 3, and 9A could increase vaccination coverage to 64.2%.
- Substituting specific serotypes in the Pneumococcal Polysaccharide Vaccine 23 (PPV-23) could elevate coverage to 91.2% for the Turkish population.
Key Insights:
- Prevalent pneumococcal serotypes in Turkey differ from those targeted by current vaccines.
- Targeted vaccine formulation adjustments can substantially improve serotype coverage.
- Statistical analysis confirms the significance of proposed vaccine modifications.
Outlook:
- Future vaccine strategies should consider regional serotype prevalence for optimal efficacy.
- Further research into novel vaccine compositions is warranted.
- Implementing updated vaccine formulations could lead to a significant reduction in pneumococcal disease burden in Turkey.
Related Concept Videos
Vaccinations
Overview
Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Infectious Diseases and Their Occurrence
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...

